Inspira Technologies Oxy B.H.N. (IINN)
Builds AME quantum-connectivity hardware while advancing respiratory support and blood-monitoring devices.
Something off on this page? Send us feedback.
Inspira is an Israeli Nasdaq-listed company now focused on AME-based quantum-connectivity hardware, while keeping its respiratory support and blood-monitoring portfolio in a dedicated medical business unit. Its main medical products include the FDA-cleared INSPIRA ART100, the INSPIRA ART500 in development, and the HYLA blood sensor.
Inspira Technologies Oxy B.H.N. Ltd. is based in Ra'anana, Israel and trades on Nasdaq. Following its April 2026 acquisition of Nano Dimension's AME platform, the company is steering its public strategy toward quantum-connectivity hardware for dilution cryostats, using additive manufacturing to create compact electronic structures for cryogenic environments. The acquired AME operations include printing systems, software, engineering know-how, customer assets, and lab facilities, while the legacy medical business continues in a dedicated unit.
That unit centers on INSPIRA ART100 for cardiopulmonary bypass, INSPIRA ART500 as a respiratory-support system in development, and HYLA as a continuous blood-monitoring sensor. Commercial execution spans AME deployment at a U.S. defense customer and hospital adoption of ART100 through distributor and clinical relationships. The company depends on integrating the acquired AME assets, securing regulatory clearance for pipeline medical products, and expanding use beyond early installations.
Company facts
Categories
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Dec 31, 2025Cash & short-term investments $3.2M · Total debt $480.0K · Total assets $5.3M · Shareholders' equity $2.3M
- Revenue
- $144.5K
- Operating income
- $3.6M
- Net income
- −$3.2M
No dividends on record.
| Institutions18 holders · as of Mar 31, 2026 | 26.58% | 6.40M ADS | |
| Insiders1 holder · as of May 15, 2025 | 6.94% | 1.67M ADS | |
| Otherremainder | 66.48% | 16.01M ADS |
24.08M ADS as of Aug 11, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Armistice Capital, LLCInstitution | 17.19% | 4.14M ADS | 13Fas of Mar 31, 2026 |
Yorkville Advisors Global, LPInstitution | 8.21% | 1.98M ADS | 13Fas of Mar 31, 2026 |
Dagi Ben-NoonInsider | 6.94% | 1.67M | 13Gfiled May 15, 2025 ↗ |
Kestra Advisory Services, LLCInstitution | 0.33% | 78,824 ADS | 13Fas of Mar 31, 2026 |
Susquehanna International Group, LLPInstitution | 0.25% | 59,733 ADS | 13Fas of Mar 31, 2026 |
| See all 25 → | |||
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
Nothing filed in the last 12 months.
Not reported.